African leadership underpins success of malaria drug trial

Norge Nyheter Nyheter

African leadership underpins success of malaria drug trial
Norge Siste Nytt,Norge Overskrifter
  • 📰 Nature
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 68%

Urgent research to bolster disease defences demands equitable responsibility and ownership between partners.

Lumefantrine is an established drug that is often used in combination with another antimalarial called artemether. But growing resistance of the malaria parasite to artemether has accelerated the hunt for a new partner for lumefantrine. “We have to think about what the alternative drug will be,” says WANECAM member Rella Zoleko Manego, a medical doctor who is running the clinical trials in Gabon at the Centre de Recherches Médicales de Lambaréné .

In September 2021, MMV and Novartis reported positive results from a separate clinical trial carried out in India and six African countries, which indicate that the ganaplacide/lumefantrine drug combination has the potential not only to clear malaria infection, including resistant strains, but could also block the transmission of the malaria parasite.

Another major factor in ensuring an equitable partnership, Sutherland says, is that much of the responsibility for managing the project’s budget lies with the African researchers. Sutherland has been involved in scientist training programmes in Africa for 20 years, and says it is significant that WANECAM also runs workshops that focus on building bureaucratic capacity, such as training local finance managers and project administrators.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Nature /  🏆 64. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

In an Era of Viral Excess, How Do Quiet Brands Make Noise?In an Era of Viral Excess, How Do Quiet Brands Make Noise?In some cases, their success lies in the fact that they don't.
Les mer »

Could drugs prevent Alzheimer’s? These trials aim to find outResearchers are giving drugs to healthy people in hope of clearing away toxic proteins in the brain and warding off neurodegeneration.
Les mer »

Car sale conversion rates stronger for agency model, says Polestar UK CEO | AutocarCar sale conversion rates stronger for agency model, says Polestar UK CEO | AutocarSuccess in this new way of selling cars will come down to customer experience
Les mer »

Patients with Vision Loss See Color Again After Landmark CRISPR ExperimentPatients with Vision Loss See Color Again After Landmark CRISPR ExperimentA clinical trial on humans was organized after preliminary trials on mice and non-human primates were shown to be both safe and encouraging.
Les mer »

Denver police arrest suspect and seize more than 200 pounds of illegal drugsDenver police arrest suspect and seize more than 200 pounds of illegal drugsA drug suspect was arrested on Thursday by Denver police and hundreds of pounds of illegal drugs and about 9,000 fentanyl tablets were seized.
Les mer »

What’s the deal? MLB player reps approved CBA after executive committee rejected it.What’s the deal? MLB player reps approved CBA after executive committee rejected it.Union leadership insists discrepancy isn't indicative of division, but stark differences in numbers indicate otherwise.
Les mer »



Render Time: 2025-03-11 05:00:33